Ryotaro Matsumoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ryotaro Matsumoto has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Masamune
Division of Gastroenterology, Tohoku University Hospital, Sendai, Japan
15 shared publications - Tetsuya Takikawa
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan
12 shared publications Kazuhiro Kikuta
9 shared publications- Akira Sasaki
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan
6 shared publications - Shin Hamada
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan
6 shared publications - Shin Miura
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan
6 shared publications
Latest Publications
- Open Access
Diabetes Trajectory and Pancreatic Cancer Detection in Patients with Diabetes: A Nationwide Survey Through Japan Diabetes Society-Certified Facilities
Background/Objectives: Diabetes mellitus (DM) and pancreatic cancer (PC) have a bidirectional relationship. Although new-onset DM (NODM) is recognized as a potential clue to PC, worsening glycemic control in long-standing DM (LSDM) may also precede PC diagnosis. We aimed to characterize patterns of PC detection in specialist diabetes practice and to examine the association between diabetes-related diagnostic triggers and stage at diagnosis. Methods: This retrospective, nationwide, two-stage survey included patients with PC and DM treated at Japan Diabetes Society-certified educational facilities between 2017 and 2021. NODM and LSDM were defined as diabetes diagnosed within and more than 3 years before PC diagnosis, respectively. Results: Among 2291 patients with PC, 549 (24.0%) had NODM and 1742 (76.0%) had LSDM. Compared with symptom-based diagnosis, diabetes-related detection was associated with a higher proportion of stage 0/IA disease (11.0% vs. 3.9%) and a lower proportion of stage IV disease (26.1% vs. 49.5%). Diabetes-related detection was independently associated with stage 0/IA disease, with an adjusted odds ratio of 2.87 (95% confidence interval, 1.72–4.81; p < 0.001). Among patients with worsening LSDM, 57.2% were diagnosed with PC within 3 months and 79.4% within 6 months. Among those with available longitudinal body-weight data, 66.9% experienced weight loss of at least 2.5% compared with 1 year before PC diagnosis. Conclusions: Potential clues to PC in diabetes practice extend beyond NODM to deterioration of pre-existing diabetes, with weight loss frequently observed among patients with available longitudinal data. Prospective studies with appropriate control groups are needed to determine which diabetes trajectories can reliably identify patients who warrant targeted pancreatic evaluation.
Open AccessDiabetes Trajectory and Pancreatic Cancer Detection in Patients with Diabetes: A Nationwide Survey Through Japan Diabetes Society-Certified Facilities
Background/Objectives: Diabetes mellitus (DM) and pancreatic cancer (PC) have a bidirectional relationship. Although new-onset DM (NODM) is recognized as a potential clue to PC, worsening glycemic control in long-standing DM (LSDM) may also precede PC diagnosis. We aimed to characterize patterns of PC detection in specialist diabetes practice and to examine the association between diabetes-related diagnostic triggers and stage at diagnosis. Methods: This retrospective, nationwide, two-stage survey included patients with PC and DM treated at Japan Diabetes Society-certified educational facilities between 2017 and 2021. NODM and LSDM were defined as diabetes diagnosed within and more than 3 years before PC diagnosis, respectively. Results: Among 2291 patients with PC, 549 (24.0%) had NODM and 1742 (76.0%) had LSDM. Compared with symptom-based diagnosis, diabetes-related detection was associated with a higher proportion of stage 0/IA disease (11.0% vs. 3.9%) and a lower proportion of stage IV disease (26.1% vs. 49.5%). Diabetes-related detection was independently associated with stage 0/IA disease, with an adjusted odds ratio of 2.87 (95% confidence interval, 1.72–4.81; p < 0.001). Among patients with worsening LSDM, 57.2% were diagnosed with PC within 3 months and 79.4% within 6 months. Among those with available longitudinal body-weight data, 66.9% experienced weight loss of at least 2.5% compared with 1 year before PC diagnosis. Conclusions: Potential clues to PC in diabetes practice extend beyond NODM to deterioration of pre-existing diabetes, with weight loss frequently observed among patients with available longitudinal data. Prospective studies with appropriate control groups are needed to determine which diabetes trajectories can reliably identify patients who warrant targeted pancreatic evaluation.
- 19 March 2026
- Published by Elsevier in Pancreatology
- Vol. 26 (3) , 469-478
Spink1 promotes the survival of Kras-mutant pancreatic acinar cells
- 19 March 2026
- Published by Elsevier in Pancreatology
- Vol. 26 (3) , 469-478
Spink1 promotes the survival of Kras-mutant pancreatic acinar cells
- 13 August 2025
- Published by Elsevier in Pancreatology
- Vol. 25 (6) , 823-831
Impact of coronavirus disease 2019 on the clinical outcomes of acute pancreatitis: a nationwide observational study in Japan
- 13 August 2025
- Published by Elsevier in Pancreatology
- Vol. 25 (6) , 823-831
Impact of coronavirus disease 2019 on the clinical outcomes of acute pancreatitis: a nationwide observational study in Japan
- 26 November 2024
- Published by Elsevier in Pancreatology
- Vol. 25 (1) , 82-88
Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan
- 26 November 2024
- Published by Elsevier in Pancreatology
- Vol. 25 (1) , 82-88
Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan
- 12 April 2024
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 17 (3) , 567-574
A case report of perihilar cholangiocarcinoma in a patient with situs inversus totalis
Situs inversus totalis is a rare congenital malformation in which organs are positioned in a mirror-image relationship to normal conditions. It often presents with vascular and biliary malformations. Only a few reports have pointed out the surgical difficulties in patients with situs inversus totalis, especially in those with perihilar cholangiocarcinoma. This report describes a 66-year-old male patient who underwent left hemihepatectomy (S5, 6, 7, and 8) with combined resection of the caudate lobe (S1), extrahepatic bile duct, and regional lymph nodes for perihilar cholangiocarcinoma with situs inversus totalis. Cholangiocarcinoma was mainly located in the perihilar area and progressed extensively into the bile duct. Surgery was performed after careful evaluation of the unusual anatomy. Although several vascular anomalies required delicate manipulation, the procedures were performed without major intraoperative complications. Postoperatively, bile leakage occurred, but the patient recovered with drainage treatment. The patient was discharged on the 29th postoperative day. Adjuvant chemotherapy with S-1 was administered for approximately 6 months. There was no recurrence 15 months postoperatively. Appropriate imaging studies and an understanding of unusual anatomy make surgery safe and provide suitable treatment for patients with situs inversus totalis.
- 12 April 2024
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 17 (3) , 567-574
A case report of perihilar cholangiocarcinoma in a patient with situs inversus totalis
Situs inversus totalis is a rare congenital malformation in which organs are positioned in a mirror-image relationship to normal conditions. It often presents with vascular and biliary malformations. Only a few reports have pointed out the surgical difficulties in patients with situs inversus totalis, especially in those with perihilar cholangiocarcinoma. This report describes a 66-year-old male patient who underwent left hemihepatectomy (S5, 6, 7, and 8) with combined resection of the caudate lobe (S1), extrahepatic bile duct, and regional lymph nodes for perihilar cholangiocarcinoma with situs inversus totalis. Cholangiocarcinoma was mainly located in the perihilar area and progressed extensively into the bile duct. Surgery was performed after careful evaluation of the unusual anatomy. Although several vascular anomalies required delicate manipulation, the procedures were performed without major intraoperative complications. Postoperatively, bile leakage occurred, but the patient recovered with drainage treatment. The patient was discharged on the 29th postoperative day. Adjuvant chemotherapy with S-1 was administered for approximately 6 months. There was no recurrence 15 months postoperatively. Appropriate imaging studies and an understanding of unusual anatomy make surgery safe and provide suitable treatment for patients with situs inversus totalis.
- 19 January 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (3) , 335-342
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
- 19 January 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (3) , 335-342
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
- 6 January 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (2) , 197-205
Skeletal muscle mass and function are affected by pancreatic atrophy, pancreatic exocrine insufficiency and poor nutritional status in patients with chronic pancreatitis
- 6 January 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (2) , 197-205
Skeletal muscle mass and function are affected by pancreatic atrophy, pancreatic exocrine insufficiency and poor nutritional status in patients with chronic pancreatitis
- 4 October 2023
- Published by Elsevier in Pancreatology
- Vol. 23 (7) , 797-804
Trends and clinical characteristics of pediatric acute pancreatitis patients in Japan: A comparison with adult cases based on a national administrative inpatient database
- 4 October 2023
- Published by Elsevier in Pancreatology
- Vol. 23 (7) , 797-804
Trends and clinical characteristics of pediatric acute pancreatitis patients in Japan: A comparison with adult cases based on a national administrative inpatient database
- Open Access
- 1 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3012
Endoscopic Grading of Gastric Intestinal Metaplasia Using Magnifying and Nonmagnifying Narrow-Band Imaging Endoscopy
Several endoscopic findings obtained by magnifying image-enhanced endoscopy (IEE) are reportedly correlated with gastric intestinal metaplasia (IM); however, the differences between magnifying and nonmagnifying IEE for the diagnosis of gastric IM remain unknown. This study included 100 consecutive patients who underwent narrow-band imaging endoscopy. Four areas of the stomach were evaluated using nonmagnifying and magnifying IEE. Light-blue crest (LBC), white opaque substance (WOS), and endoscopic grading of the gastric IM (EGGIM) were assessed. The concordance rates between nonmagnifying and magnifying IEE were 80.5% for LBC and 93.3% for WOS. The strength of agreement between each observation technique showed good reproducibility, with a kappa value of 0.69 and 0.83 for LBC and WOS, respectively. The individual EGGIM score indicated a good correlation between nonmagnifying and magnifying IEE (concordance rate, 75%; kappa value, 0.67). The prevalence of a high EGGIM score in patients with and without gastric cancer (GC) showed a significant difference both with nonmagnifying IEE (odds ratio (OR), 3.3; 95% confidence interval (CI), 1.2–9.0), and magnifying IEE (OR, 3.1; 95% CI, 1.1–8.9). Nonmagnifying IEE has the potential to stratify the individual risk of GC, similar to magnifying IEE, warranting further investigation with histological assessment.
- 1 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3012
Open AccessEndoscopic Grading of Gastric Intestinal Metaplasia Using Magnifying and Nonmagnifying Narrow-Band Imaging Endoscopy
Several endoscopic findings obtained by magnifying image-enhanced endoscopy (IEE) are reportedly correlated with gastric intestinal metaplasia (IM); however, the differences between magnifying and nonmagnifying IEE for the diagnosis of gastric IM remain unknown. This study included 100 consecutive patients who underwent narrow-band imaging endoscopy. Four areas of the stomach were evaluated using nonmagnifying and magnifying IEE. Light-blue crest (LBC), white opaque substance (WOS), and endoscopic grading of the gastric IM (EGGIM) were assessed. The concordance rates between nonmagnifying and magnifying IEE were 80.5% for LBC and 93.3% for WOS. The strength of agreement between each observation technique showed good reproducibility, with a kappa value of 0.69 and 0.83 for LBC and WOS, respectively. The individual EGGIM score indicated a good correlation between nonmagnifying and magnifying IEE (concordance rate, 75%; kappa value, 0.67). The prevalence of a high EGGIM score in patients with and without gastric cancer (GC) showed a significant difference both with nonmagnifying IEE (odds ratio (OR), 3.3; 95% confidence interval (CI), 1.2–9.0), and magnifying IEE (OR, 3.1; 95% CI, 1.1–8.9). Nonmagnifying IEE has the potential to stratify the individual risk of GC, similar to magnifying IEE, warranting further investigation with histological assessment.